(SACRAMENTO, Calif.) – A thorough review of the medications approved to treat Alzheimer’s disease and other age-related dementia will be the subject of the next UC Davis Alzheimer’s Disease Center 2014 Community Engagement Series lecture.
The lecture, “Medications in Dementia: Are they Useful or Harmful?” will be delivered by Glen Xiong, associate clinical professor in the UC Davis Department of Psychiatry and Behavioral Sciences. The lecture will provide a comprehensive review of the benefits and deficits of U.S. Food and Drug Administration-approved Alzheimer’s medications, as well as an overview of psychiatric medications commonly prescribed to treat the related behavioral symptoms of Alzheimer’s.
The event will be held Thursday, July 24, at 6 p.m. in the auditorium of the UC Davis MIND Institute, 2825 50th St., Sacramento.
Xiong is the associate director of education at the Alzheimer’s Disease Center. He teaches and practices at the Sacramento County Mental Health Treatment Center, where he serves as medical director. He also provides consultation to long-term care facilities, especially in the area of appropriate medication usage and dosing.
The event is free and open to the public. Reservations are required. For further information or to RSVP, please 916-734-5728.
The UC Davis Alzheimer’s Disease Center is one of only 27 research centers designated by the National Institutes of Health’s National Institute on Aging. The center’s goal is to translate research advances into improved diagnosis and treatment for patients while focusing on the long-term goal of finding a way to prevent or cure Alzheimer’s disease. Also funded by the state of California, the center allows researchers to study the effects of the disease on a uniquely diverse population. For more information, visit http://alzheimer.ucdavis.edu.